DAIICHI SANKYO, INC.
DAIICHI SANKYO, INC.
別名
第一三共 INC.
別名
DAIICHI SANKYO, INC.(第一三共 INC.)
別名
Daiichi Sankyo, Inc.
別名
United States of America
Pharmaceutical development and manufacturing
Research and development of cardiovascular and oncology drugs
Clinical trials and regulatory affairs
Global distribution of pharmaceutical products
Oncology
Bone Health
Nephrology
Inflammatory Diseases
Biologic Products
Specialty Medicines
Clinical Research
Investigational Product Access
Collaborative Research
Cardiovascular
Diabetes
Gastrointestinal
Antibiotic
Drug discovery and development
Clinical research and trials
会社名
Group
親会社
子会社
得意先
仕入先
業務提携
銀行等
株主等
Spectrum Pharmaceuticals
Group
1 件
| 日付 | 概要 |
|---|
| 2022-05-27 |
At Daiichi Sankyo, we proudly observe Asian Pacific American Heritage Month (APAHM) in May. During this month, we recognize our own Asian heritage—Daiichi Sankyo is a global company based in Japan with more than 100 years of history in medical science. We also take this time to honor the achievements of Asians and Pacific Islanders to our society and our organization. We encourage open conversations and amplify the voices of our employees representing the Pan-Asian diaspora. We promote active steps toward inclusion and diversity, emphasizing cultural humility and understanding marginalized communities' histories and struggles. Fay Dunbar, Director of Inclusion & Diversity, stated that inclusion is key to unlocking the power of our people and that the company is committed to a diverse workplace reflecting the world and the patients served. |
2026-08-03 09:53 (Model: ggml-org/gpt-oss-20b )
